These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4577401)

  • 1. [Antibacterial activity of nitrooxyquinoline studied in 2 experimental models of pyelonephritis induced by Escherichia coli in rats].
    Hatala M; Hnátek J; Liska M; Konícková L; Uhlír O; Prát V
    Cas Lek Cesk; 1973; 112(23):722-5. PubMed ID: 4577401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Animal studies on antibacterial activity of 10 cephalosporins (author's transl)].
    Marre R; Züllich B; Beck H; Sack K
    Zentralbl Bakteriol Orig A; 1978 Jun; 240(4):529-37. PubMed ID: 358677
    [No Abstract]   [Full Text] [Related]  

  • 3. [Comparison of antibacterial effect of rifampicin and cephaloridine on a model of E. coli pyelonephritis in rats].
    Prát V; Konícková L; Hatala M
    Arzneimittelforschung; 1970 Apr; 20(4):554-7. PubMed ID: 4911591
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nalidixic acid sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prát V; Konicková L
    Arch Hyg Bakteriol; 1969 Jun; 153(3):254-9. PubMed ID: 4908403
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ciprofloxacin and cefotaxim: pharmacokinetic and therapeutic effectiveness in E. coli pyelonephritis in rats].
    Tietgen K; Schulz E; Boness J; Marre R
    Immun Infekt; 1986 Jul; 14(4):152-5. PubMed ID: 2943665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibacterial effect of two sulfonamide compoundds in acute experimental E. coli-pyelonephritis].
    Konicková L; Prát V; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1969 Oct; 19(10):1717-20. PubMed ID: 4902491
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of antibacterial effect of ampicillin on ascending E. coli pyelonephritis in rats].
    Konícková L; Prát V; Hatala M
    Cesk Farm; 1969 Jun; 18(4):206-8. PubMed ID: 4895577
    [No Abstract]   [Full Text] [Related]  

  • 8. Piromidic acid and beta-hydroxypiromidic acid: therapeutic effectiveness on experimental E. coli pyelonephritis in the rat.
    Loew H; Ritzerfeld W
    Int J Clin Pharmacol; 1973 Apr; 7(2):234-7. PubMed ID: 4581342
    [No Abstract]   [Full Text] [Related]  

  • 9. [5-nitro-8-oxyquinoline in the treatment of chronic pyelonephritis].
    Leńko J; Markiewicz K; Trznadel K
    Pol Tyg Lek; 1974 Jun; 29(24):1045-7. PubMed ID: 4602504
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental therapeutic study on hormonally facilitated pyelonephritis in an acute and chronic test].
    Koch HG; Freiesleben H; Henkel W; Commichau R
    Verh Dtsch Ges Inn Med; 1971; 77():1336-9. PubMed ID: 4949696
    [No Abstract]   [Full Text] [Related]  

  • 11. [The antibiotic effect of gentamycin in experimental acute Escherichia coli pyelonephritis].
    Ritzerfeld W; Prat V; Konickova L; Losse H
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):254-8. PubMed ID: 4880994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Antibacterial effect of nalidixic acid in experimental acute Escherichia coli pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arztl Forsch; 1968 Feb; 22(2):69-72. PubMed ID: 4876157
    [No Abstract]   [Full Text] [Related]  

  • 13. [Methodical contribution to the evaluation of antibacterial efficacy of some chemotherapeutic agents in experimental pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Int Z Klin Pharmakol Ther Toxikol; 1969 Jan; 2(1):20-5. PubMed ID: 4896483
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibacterial effect of nitrofurantoin in acute, ascending E. coli pyelonephritis of rats].
    Konícková L; Prát V; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Jun; 18(6):720-2. PubMed ID: 4885094
    [No Abstract]   [Full Text] [Related]  

  • 15. Antibiotic activity of cefazedone in experimental pyelonephritis.
    Quante T; Ritzerfeld W
    Arzneimittelforschung; 1979; 29(2a):417-8. PubMed ID: 385010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on chloramphenicol sensitivity of an E. coli strain in experimental pyelonephritis].
    Hatala M; Ritzerfeld W; Prat V; Konickova L; Losse H
    Arch Hyg Bakteriol; 1968 Apr; 152(2):181-6. PubMed ID: 4884481
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunological defense and virulence of the agent in experimental chronic infection].
    Henkel W; Freiesleben H; Wöhrmann W; Krüger C; Commichau R
    Zentralbl Bakteriol Orig A; 1974; 227(1-4):306-13. PubMed ID: 4154602
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of chloramphenicol against different E. coli strains in vitro and in experimental pyelonephritis].
    Prát V; Konícková L; Ritzerfeld W; Losse H
    Arzneimittelforschung; 1968 Sep; 18(9):1123-7. PubMed ID: 4885372
    [No Abstract]   [Full Text] [Related]  

  • 19. Investigations on the effectiveness of cefazedone in experimental E. coli pyelonephritis.
    Sack K; Marre R; Freiesleben H; Henkel W
    Arzneimittelforschung; 1979; 29(2a):414-6. PubMed ID: 385009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistological, histological and bacteriological studies of acute experimental coli-pyelonephritis of the rat treated with sulfisomidine and prednisolone].
    Dutz W; Ernst B; Hagemann I; Jacob M; Rohde E; Ziegler PF
    Acta Biol Med Ger; 1965; 15(4):480-91. PubMed ID: 5335615
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.